North Bud Farms (NBUD) positions itself as a 'second-mover' in the Canadian cannabis space, aiming to avoid the pitfalls of early industry pioneers by focusing on the high-margin 'Legalization 2.0' segment of infused products. The deck highlights a heavy infrastructure play, leveraging 95 acres of company-owned land in Low, Québec, situated just 10km from the Paugan Dam to secure the lowest electricity rates in Canada. With a phased build-out plan, the company projects an eventual annual production of 12,000,000 grams and prospective revenue of $12M CDN per annum. The presentation relies heav…
Key takeaways
- The company identifies as a raw input producer for Cannabinoid Infused Products (CIP), targeting the 2019 Canadian regulatory opening (Slide 5).
- NBUD explicitly adopts a 'second-mover advantage' strategy, comparing itself to Google and Facebook while labeling early movers like AOL and BlackBerry as having 'first-mover disadvantage' (Slide 7).
- The board features significant political and medical weight, including a former Canadian Minister of Health and a New York Board-certified psychopharmacologist (Slide 9).
- Infrastructure is a core competitive moat, citing 95 acres of owned land and proximity to the Paugan Dam for the lowest cost per kWh in Canada (Slide 11).
- Phase 1 construction involves a 25,000 sq. ft. facility, with a massive Phase 2 expansion to 500,000 sq. ft. expected in Q2 2020 (Slide 11).
- Revenue projections are based on a conservative $1,000 per kg price point, despite a stated current market average of $4,500 per kg (Slide 13).
- The company seeks $4.8M for the Phase 1 build-out, with $4.2M allocated to the production facility and $600,000 to operating costs (Slide 15).
- The investment thesis rests on 'unlimited electrical supply' and available government subsidies in Low, Québec (Slide 17).
North Bud Farms: The Infrastructure-First Approach to Cannabinoids
The investor presentation for North Bud Farms (CSE: NBUD), dated January 15, 2019, represents a specific era of the Canadian cannabis market. At this time, the industry was transitioning from 'Legalization 1.0' (dried flower) to 'Legalization 2.0' (extracts, edibles, and topicals). NBUD’s deck is a study in positioning a company not as a trendy consumer brand, but as a disciplined industrial supplier leveraging geographic and regulatory advantages.
Slide 1: Title and Public Listing
The cover slide establishes the company's identity with a bold, block-letter logo and its public ticker, CSE: NBUD. The date, January 15, 2019, places the deck just months before the anticipated regulatory shift in Canada regarding infused products. The minimalism of the slide suggests a corporate, rather than lifestyle, focus.
Slide 3: The Mission Statement
NBUD defines its mission as focusing on 'sustainable low cost, high quality cannabinoid production.' The slide identifies two specific target client bases: bio-pharmaceutical development and Cannabinoid Infused Products (CIP). This is a crucial distinction; the company is positioning itself as an upstream supplier in the value chain, avoiding the volatile retail consumer market to focus on B2B extraction and pharmaceutical inputs.
Slide 5: Legalization 2.0 and Market Positioning
This slide serves as the 'Problem/Opportunity' section. It notes that the Canadian regulatory door for CIP was opening in 2019. Citing established legal jurisdictions like Colorado, Washington, Nevada, and California, NBUD claims the infused products sector is the 'highest margin segment of the industry.' The company explicitly states its goal: to be a 'raw input producer' providing standardized inputs for large-scale GMP (Good Manufacturing Practice) manufacturing. This slide emphasizes that they are already working with food, beverage, and science companies, though no specific partners are named.
Slide 7: The Second-Mover Argument
In one of the more unique strategic pivots in cannabis decks of this era, NBUD argues against the necessity of being first. Slide 7 lists AOL, Netscape, Yahoo, and BlackBerry as examples of 'first-mover disadvantage.' Conversely, it groups NORTHBUD with Google, Facebook, Amazon, and Apple as 'second movers' who benefit from a 'clearer picture of market and competition.' This is an attempt to frame their later entry into the market as a calculated advantage rather than a lack of momentum.
Slide 9: The Board of Directors
The 'Experienced Board' slide is arguably the strongest in the deck. It features five individuals with high-level experience in government, big tobacco, and pharmacy. Leona Aglukkaq is highlighted as a former Canadian Minister of Health and Minister of the Environment, providing significant regulatory credibility. Michael Saxon brings experience from Altria and Philip Morris International, while Dr. Teresa DeLuca offers pharmaceutical and clinical sales expertise from Walgreen Co. and Magellan. The inclusion of these figures is intended to signal to investors that the company is 'grown-up' and capable of navigating complex legal landscapes.
Slide 11: Site Details and Low-Cost Infrastructure
This slide moves into the physical assets of the company. NBUD highlights 95 acres of company-owned land in Low, Québec. The primary competitive advantage cited here is the proximity (10 km) to the Paugan Dam , which provides the 'lowest cost per kWh in Canada.' The slide includes satellite imagery of the site and outlines a two-phase build-out: a 25,000 sq. ft. facility (Phase 1) where construction had already begun, and a massive 500,000 sq. ft. expansion (Phase 2) expected by Q2 2020.
Slide 13: Revenue Projections
NBUD provides specific production and revenue targets. For Phase 1, they estimate 200g per sq. ft. of annualized production, totaling 800 kg before obtaining a sales license. For Phase 2, the projection jumps to 12,000,000 grams per year. The financial 'hook' is the prospective revenue of $12M CDN per annum . Notably, the company uses a conservative price assumption of $1,000 per kg, despite stating that the current market average at the time was $4,500 per kg. This conservative modeling is a tactic to build investor trust in the feasibility of the numbers.
Slide 15: Use of Proceeds
The financial ask is clearly defined on slide 15. The company seeks $4.8M for the Phase 1 build-out. The breakdown is simple: $4.2M for the production facility and $600,000 for operation costs. The lack of complexity in this slide is effective, though it does not detail how the much larger Phase 2 expansion would be funded.
Slide 17: Investment Merits
This slide summarizes the pitch into two categories: Team and Scalability. It reiterates the 'public company experience' of the executives and the expertise of the Chief Cultivation Officer (who is mentioned but not pictured on the team slide). It also reinforces the 'unlimited electrical supply' and 'low-cost labour & municipal taxes' associated with their Québec location, mentioning available government subsidies as an additional perk.
Slide 19: Contacts
The final slide provides direct contact information for Edward Miller (VP, Investor Relations) and Ryan Brown (CEO), including phone numbers and email addresses. This maintains the professional, accessible tone of the presentation.
What North Bud Farms Does Well
The deck excels at geographic storytelling . By focusing on the Paugan Dam and the specific electricity rates in Québec, NBUD turns a commodity business (growing plants) into a structural advantage. In a market where many companies were over-promising on brand and lifestyle, NBUD’s focus on being the 'lowest-cost producer' is a refreshing and logical value proposition for institutional investors.
The Board of Directors slide is also a masterclass in 'borrowed credibility.' By listing a former Health Minister and a former Philip Morris executive, they address the two biggest risks in cannabis: regulation and scale. The 'second-mover' framing is also a clever way to address the fact that they were not among the first wave of Licensed Producers (LPs) in Canada.
What is Missing from the Deck
The most glaring omission is a detailed executive team slide . While the board is impressive, the day-to-day operators—aside from the CEO—are not introduced. Investors generally want to see the 'doers' as much as the 'advisors.' There is also no mention of unit economics beyond the top-line revenue projection. While they mention low electricity costs, they do not provide a projected 'cost per gram' to produce, which is the standard metric for evaluating cultivation efficiency.
Furthermore, the deck lacks a competitive landscape analysis. While they mention being a 'second mover,' they do not name the 'first movers' they intend to disrupt or explain how they will compete with other low-cost producers who might also have access to cheap power in other regions. Finally, there is no exit strategy or clear timeline for investor liquidity, though the public ticker implies that liquidity is already available via the open market.
Founder Takeaways: Copy the Logic, Not the Layout
Founders should emulate NBUD’s conservative financial modeling . By projecting revenue based on $1,000/kg while the market was at $4,500/kg, they created a 'margin of safety' that makes the $12M revenue target feel achievable rather than aspirational. This builds significant credibility during due diligence.
The structural moat argument is also worth copying. If your business relies on a specific input (power, water, specialized labor), find a way to prove that you have the 'lowest cost' version of that input. NBUD didn't just say they had cheap power; they named the dam and the distance to it. Specificity creates the illusion of inevitability, which is a powerful tool in fundraising.
Frequently asked questions
- What is North Bud Farms' primary business model?
- North Bud Farms operates as a B2B raw input producer. According to slide 5, they focus on providing safe, standardized cannabinoid-infused raw inputs for large-scale GMP manufacturing. They target clients in the bio-pharmaceutical development and Cannabinoid Infused Products (CIP) sectors, rather than selling directly to consumers under their own brand name.
- How does the company justify its 'second-mover' strategy?
- On slide 7, the company argues that first movers often face disadvantages, citing AOL and Yahoo as examples. They claim that as a second mover, they have a 'clearer picture of market and competition.' This allows them to enter the market during 'Legalization 2.0,' focusing on high-margin infused products rather than the initial rush for flower.
- What are the specific details of their cultivation facility?
- Slide 11 and 13 detail a two-phase approach. Phase 1 is a 25,000 sq. ft. facility with 7,400 sq. ft. of flowering space, projected to produce 800 kg annually. Phase 2 plans for a 500,000 sq. ft. outdoor cultivation expansion by Q2 2020, intended to bring total annual production to 12,000,000 grams.
- Who are the key members of the North Bud Farms leadership?
- The deck emphasizes the board over the executive team. Key figures on slide 9 include CEO Ryan Brown (co-founder of Tetra Bio-Pharma), André Audet (Chairman), Michael Saxon (former Altria/Philip Morris executive), Leona Aglukkaq (former Canadian Minister of Health), and Dr. Teresa DeLuca (psychopharmacologist and former VP at Walgreen Co.).
- What is the financial 'ask' and how will the funds be used?
- Slide 15 outlines a 'Use of Proceeds' totaling $4.8M. The majority of this capital, $4.2M, is earmarked for the construction of the 'Low Production Facility' (Phase 1). The remaining $600,000 is allocated to operational costs. The deck does not specify the equity percentage offered or the valuation.
